Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product, a treatment that works by stopping HIV from getting ...
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Zacks.com on MSN2d
Gilead, MRK Report Data From Investigational Combination Study for HIVGilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...
Believe it or not, many people at this very moment are going through life, completely unaware that they may be living with ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Study looked at 198 kidney transplants, found similar results whether donated organ came from person with or without AIDS ...
Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...
The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...
People with HIV can safely receive donated kidneys from deceased donors with the virus, according to a large study that comes ...
especially those where HIV incidence is highest. Last week, Gilead made its highly anticipated public statement. The company has signed voluntary licensing agreements with six drug companies who will ...
The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...
People with HIV can safely receive donated kidneys from deceased donors with the virus, according to a large US study that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback